{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:44:43Z","timestamp":1782693883663,"version":"3.54.5"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL171293"],"award-info":[{"award-number":["R01HL171293"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Obesity"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study compared changes in health care costs and use across cohorts initiating four obesity medications (OMs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Commercial insurance claims were used to identify new initiators of phentermine (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009136,788), phentermine\u2010topiramate\u2010ER (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913,888), naltrexone\u2010bupropion\u2010SR (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200928,712), or liraglutide (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200949,266) for obesity. Multivariable difference\u2010in\u2010differences analyses compared the three newer drugs to phentermine for change in total annual prescription drug and health care costs, outpatient visits, and acute care use (combined emergency department visits and hospital stays).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Up to 3\u2009years after OM initiation, prescription and total health care costs were higher for all three newer OM cohorts relative to phentermine, with liraglutide having the greatest comparative increase in annual costs (e.g., total costs 73.6% [70.9%, 76.3%] higher in year 1). Primary care physician visit frequency was slightly lower for the newer OMs (e.g., \u221212.6% [\u221213.6%, \u221211.6%] in year 1 for liraglutide).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The cost of OM treatment, even for medications that preceded highly effective weekly incretin analogues, appeared to increase overall prescription spending and total health care costs. Yet, other than a relative decrease in primary care physician visit frequency, more costly OMs were not associated with favorable changes in health care use patterns compared to generic phentermine. Reductions in OM cost and other interventions to support their longer\u2010term use may be needed to fully realize the promise of these medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/oby.70208","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:18:32Z","timestamp":1778642312000},"page":"1331-1342","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health Care Costs and Use of Patients Prescribed Four Different Obesity Medications"],"prefix":"10.1002","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-7230","authenticated-orcid":false,"given":"Kristina H.","family":"Lewis","sequence":"first","affiliation":[{"name":"Department of Epidemiology &amp; Prevention, Department of Implementation Science, Division of Public Health Sciences Wake Forest University Health Sciences  Winston\u2010Salem North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"LeCates","sequence":"additional","affiliation":[{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Argetsinger","sequence":"additional","affiliation":[{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Albert","sequence":"additional","affiliation":[{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha S.","family":"Iyer","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Wharam","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"},{"name":"Department of Medicine Duke University  Durham North Carolina USA"},{"name":"Duke\u2010Margolis Center for Health Policy Duke University  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5208-8492","authenticated-orcid":false,"given":"David E.","family":"Arterburn","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Ross\u2010Degnan","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sengwee","family":"Toh","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Population Medicine Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014\u20103415"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP161365.GL"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.08.045"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.191707"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22581"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21533"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57232"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS\u201024\u201002870"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.33326"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23952"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.23332"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.13172"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.2525"},{"key":"e_1_2_9_15_1","unstructured":"R.Robbins \u201cBuried in Wegovy Costs North Carolina Will Stop Paying for Obesity Drugs \u201dNew York Times January 26 2024 https:\/\/www.nytimes.com\/2024\/01\/26\/business\/obesity\u2010drugs\u2010insurance\u2010north\u2010carolina.html."},{"key":"e_1_2_9_16_1","unstructured":"University of Michigan Human Resources \u201cLifetime Drug Limits (Infertility GLP\u20101 Drugs for Weight Loss) \u201dhttps:\/\/hr.umich.edu\/benefits\u2010wellness\/health\u2010well\u2010being\/prescription\u2010drug\u2010plan\/news\u2010updates\u2010october\u20102023\/coverage\u2010drug\u2010information\/lifetime\u2010drug\u2010limits\u2010infertility\u2010glp\u20101\u2010drugs\u2010weight\u2010loss."},{"issue":"3","key":"e_1_2_9_17_1","first-page":"1","article-title":"Upcoming Changes to MassHealth Coverage of Weight Loss Drugs","volume":"14","author":"MassHealth Pharmacy Program","year":"2024","journal-title":"Prescriber e\u2010Letter"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16531"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.0905"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2300516"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16627"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.10.004"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000824"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.16153"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23\u20101965"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.2307\/2531734"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1765(03)00032-6"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP161356.ESGL"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202405_36181"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.12788\/fp.0413"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366\u2010024\u201001467\u2010w"},{"key":"e_1_2_9_32_1","unstructured":"J.Ducharme \u201cAs Insurers Struggle With GLP\u20101 Drug Costs Some Seek to Wean Patients Off \u201d KFF Health News published September 4 2025 https:\/\/kffhealthnews.org\/news\/article\/glp\u20101\u2010weight\u2010loss\u2010diabetes\u2010drugs\u2010cost\u2010deprescription\u2010medicaid\u2010north\u2010carolina\/."},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.024927"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20309"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411892"},{"key":"e_1_2_9_36_1","unstructured":"ADIPEX\u2010P (phentermine hydrochloride USP) prescribing information (TEVA Pharmaceuticals 2012) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/085128s065lbl.pdf."},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13679\u2010023\u201000546\u20109"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000004972"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183"}],"container-title":["Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/oby.70208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/oby.70208","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/oby.70208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:03:30Z","timestamp":1782691410000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.70208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/oby.70208"],"URL":"https:\/\/doi.org\/10.1002\/oby.70208","archive":["Portico"],"relation":{},"ISSN":["1930-7381","1930-739X"],"issn-type":[{"value":"1930-7381","type":"print"},{"value":"1930-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"2026-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}